Emmaus Life Sciences Inc
OTC:EMMA

Watchlist Manager
Emmaus Life Sciences Inc Logo
Emmaus Life Sciences Inc
OTC:EMMA
Watchlist
Price: 0.013 USD 30% Market Closed
Market Cap: 830.3k USD

Wall Street
Price Targets

EMMA Price Targets Summary
Emmaus Life Sciences Inc

There are no price targets for EMMA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Emmaus Life Sciences Inc Competitors:
Price Targets
2DT
Amneal Pharmaceuticals Inc
11% Upside
HROW
Harrow Health Inc
52% Upside
4503
Astellas Pharma Inc
7% Downside
1093
CSPC Pharmaceutical Group Ltd
36% Upside
4507
Shionogi & Co Ltd
3% Downside
ABBOTINDIA
Abbott India Ltd
30% Upside
2M7C
China Medical System Holdings Ltd
23% Upside
GSK
GlaxoSmithKline PLC
1% Upside

Revenue
Forecast

Revenue Estimate
Emmaus Life Sciences Inc

For the last 12 years the compound annual growth rate for Emmaus Life Sciences Inc's revenue is 51%. The projected CAGR for the next 1 year is 40%.

51%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Emmaus Life Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
20%
Average Beat

Net Income
Forecast

Net Income Estimate
Emmaus Life Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EMMA's stock price target?
Not Available

EMMA doesn't have any price targets made by Wall Street professionals.

What is Emmaus Life Sciences Inc's Revenue forecast?
Projected CAGR
40%

For the last 12 years the compound annual growth rate for Emmaus Life Sciences Inc's revenue is 51%. The projected CAGR for the next 1 year is 40%.

Back to Top